Cargando…
Author Correction: Aberrant expression of the COX2/PGE(2) axis is induced by activation of the RAF/MEK/ERK pathway in BRAF(V595E) canine urothelial carcinoma
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7595033/ https://www.ncbi.nlm.nih.gov/pubmed/33116270 http://dx.doi.org/10.1038/s41598-020-75949-y |
_version_ | 1783601767130333184 |
---|---|
author | Yoshitake, Ryohei Saeki, Kohei Eto, Shotaro Shinada, Masahiro Nakano, Rei Sugiya, Hiroshi Endo, Yoshifumi Fujita, Naoki Nishimura, Ryohei Nakagawa, Takayuki |
author_facet | Yoshitake, Ryohei Saeki, Kohei Eto, Shotaro Shinada, Masahiro Nakano, Rei Sugiya, Hiroshi Endo, Yoshifumi Fujita, Naoki Nishimura, Ryohei Nakagawa, Takayuki |
author_sort | Yoshitake, Ryohei |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7595033 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-75950332020-10-29 Author Correction: Aberrant expression of the COX2/PGE(2) axis is induced by activation of the RAF/MEK/ERK pathway in BRAF(V595E) canine urothelial carcinoma Yoshitake, Ryohei Saeki, Kohei Eto, Shotaro Shinada, Masahiro Nakano, Rei Sugiya, Hiroshi Endo, Yoshifumi Fujita, Naoki Nishimura, Ryohei Nakagawa, Takayuki Sci Rep Author Correction Nature Publishing Group UK 2020-10-28 /pmc/articles/PMC7595033/ /pubmed/33116270 http://dx.doi.org/10.1038/s41598-020-75949-y Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Author Correction Yoshitake, Ryohei Saeki, Kohei Eto, Shotaro Shinada, Masahiro Nakano, Rei Sugiya, Hiroshi Endo, Yoshifumi Fujita, Naoki Nishimura, Ryohei Nakagawa, Takayuki Author Correction: Aberrant expression of the COX2/PGE(2) axis is induced by activation of the RAF/MEK/ERK pathway in BRAF(V595E) canine urothelial carcinoma |
title | Author Correction: Aberrant expression of the COX2/PGE(2) axis is induced by activation of the RAF/MEK/ERK pathway in BRAF(V595E) canine urothelial carcinoma |
title_full | Author Correction: Aberrant expression of the COX2/PGE(2) axis is induced by activation of the RAF/MEK/ERK pathway in BRAF(V595E) canine urothelial carcinoma |
title_fullStr | Author Correction: Aberrant expression of the COX2/PGE(2) axis is induced by activation of the RAF/MEK/ERK pathway in BRAF(V595E) canine urothelial carcinoma |
title_full_unstemmed | Author Correction: Aberrant expression of the COX2/PGE(2) axis is induced by activation of the RAF/MEK/ERK pathway in BRAF(V595E) canine urothelial carcinoma |
title_short | Author Correction: Aberrant expression of the COX2/PGE(2) axis is induced by activation of the RAF/MEK/ERK pathway in BRAF(V595E) canine urothelial carcinoma |
title_sort | author correction: aberrant expression of the cox2/pge(2) axis is induced by activation of the raf/mek/erk pathway in braf(v595e) canine urothelial carcinoma |
topic | Author Correction |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7595033/ https://www.ncbi.nlm.nih.gov/pubmed/33116270 http://dx.doi.org/10.1038/s41598-020-75949-y |
work_keys_str_mv | AT yoshitakeryohei authorcorrectionaberrantexpressionofthecox2pge2axisisinducedbyactivationoftherafmekerkpathwayinbrafv595ecanineurothelialcarcinoma AT saekikohei authorcorrectionaberrantexpressionofthecox2pge2axisisinducedbyactivationoftherafmekerkpathwayinbrafv595ecanineurothelialcarcinoma AT etoshotaro authorcorrectionaberrantexpressionofthecox2pge2axisisinducedbyactivationoftherafmekerkpathwayinbrafv595ecanineurothelialcarcinoma AT shinadamasahiro authorcorrectionaberrantexpressionofthecox2pge2axisisinducedbyactivationoftherafmekerkpathwayinbrafv595ecanineurothelialcarcinoma AT nakanorei authorcorrectionaberrantexpressionofthecox2pge2axisisinducedbyactivationoftherafmekerkpathwayinbrafv595ecanineurothelialcarcinoma AT sugiyahiroshi authorcorrectionaberrantexpressionofthecox2pge2axisisinducedbyactivationoftherafmekerkpathwayinbrafv595ecanineurothelialcarcinoma AT endoyoshifumi authorcorrectionaberrantexpressionofthecox2pge2axisisinducedbyactivationoftherafmekerkpathwayinbrafv595ecanineurothelialcarcinoma AT fujitanaoki authorcorrectionaberrantexpressionofthecox2pge2axisisinducedbyactivationoftherafmekerkpathwayinbrafv595ecanineurothelialcarcinoma AT nishimuraryohei authorcorrectionaberrantexpressionofthecox2pge2axisisinducedbyactivationoftherafmekerkpathwayinbrafv595ecanineurothelialcarcinoma AT nakagawatakayuki authorcorrectionaberrantexpressionofthecox2pge2axisisinducedbyactivationoftherafmekerkpathwayinbrafv595ecanineurothelialcarcinoma |